SCHEMBL31447482

SCHEMBL31447482

CCOc1cc([C@H](C)N)ccc1F

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.41
ALDH1A1 P00352 4/20 0.41
TSHR P16473 2/20 0.41
HPGD P15428 2/20 0.41
HSD17B10 Q99714 2/20 0.41
MAPT P10636 2/20 0.41
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 2/20 0.39
KDM1A O60341 2/20 0.39
ADRB2 P07550 1/20 0.38
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 1/20 0.37
MAPK1 P28482 1/20 0.37
KMT2A Q03164 1/20 0.37
HRH4 Q9H3N8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28408399 1.00 HTT (0.44) HTTL3MBTL1ALDH1A1TSHRHPGD
SCHEMBL20188092 0.87 MAPT (0.39) HTTL3MBTL1ALDH1A1HSD17B10MAPT
SCHEMBL18374263 0.87 MAPT (0.39) HTTL3MBTL1ALDH1A1HSD17B10MAPT
SCHEMBL13877330 0.86 KDM1A (0.49) L3MBTL1ALDH1A1HPGDHSD17B10MAPT
SCHEMBL10206356 0.86 HTT (0.46) HTTL3MBTL1ALDH1A1TSHRHPGD
Hydrochloric Acid SCHEMBL20338506 0.85 KDM4E (0.41) HTTL3MBTL1ALDH1A1MAPTPOLB
Hydrochloric Acid SCHEMBL20338505 0.85 KDM4E (0.41) HTTL3MBTL1ALDH1A1MAPTPOLB
Hydrochloric Acid SCHEMBL4235164 0.85 KDM1A (0.48) L3MBTL1ALDH1A1HPGDHSD17B10MAPT
SCHEMBL20201941 0.85 ALDH1A1 (0.44) ALDH1A1KDM1AADRB2
SCHEMBL18713475 0.84 HTT (0.49) HTTL3MBTL1ALDH1A1TSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072265-A1 SOMATOSTATIN SUBTYPE RECEPTOR 3 (SSTR3) AGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. (US) 2025-04-03 WO disclosed